Maryam Mehdipour retweeted
🎉 The wait is over!
Meet the 50 Leading Voices of The Pathologist Power List 2026, celebrating the people driving ideas, innovation and change across pathology and laboratory medicine.
🔬 Discover the list: ow.ly/AZMK50ZTpTg
#PowerList2026 #Pathology #LaboratoryMedicine
Maryam Mehdipour retweeted
Recognition. Inspiration. Celebration.
Congratulations to Donald S. Karcher, MD, FCAP, recipient of the CAP Pathologist of the Year Award—the highest honor bestowed by the College of American Pathologists.
Join us at the #CAP26 Honors in Pathology Ceremony as we celebrate Dr. Karcher's exceptional service, leadership, and contributions to pathology.
Don't miss out. Register today! events.cap.org/event/CAP26/h…
Maryam Mehdipour retweeted
Wow! Dr. @Andres_Matoso teachings on MMR IHC interpretation (Note: you can replace the 2nd floating person w/🪁 kite or 🎈). MLH1 and PMS2 hold hands (heterodimer). If MLH1 is lost, PMS2 will also be lost. If PMS2 is lost, MLH1 remains. @Blake_A_Johnson #Surgpath #Pathtwitter
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO

ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Maryam Mehdipour retweeted
#GUpath bladder bx for patient with hematuria and erythematous patch
🔬sneaky "undermining" pattern urothelial CIS
(notice transition from benign at left)
Maryam Mehdipour retweeted
“Be like a tree and let the dead leaves drop. Be like the sky and remain open.”
Rumi
Maryam Mehdipour retweeted
"Rule of thumb" in Pulmonary Cytopath - "When in lung, always think lung first". This patient with a high Gleason grade prostatic CA was clinically, radiologically & cytopathologically (macronucleoli) was thought to have mets till the IHCs came back positive for TTF-1 & NapsinA.
Maryam Mehdipour retweeted
Frozen sections reporting recommendations - Periprosthetic joint infections
Dr. Reith- Comprehensive and Immersive Soft Tissue Pathology Course-May 2025 #pathology #BSTPath #PathX
Maryam Mehdipour retweeted
Excited for the chance to connect with colleagues and attend some truly inspiring talks. #USCAP2025 #Pathology @IrenaManukyan @SihemSh @MaryamMpd
Maryam Mehdipour retweeted
Proud to present my work at #USCAP25 in Boston alongside my amazing mentor @SamankanMD @GWPathology #Pathology
Maryam Mehdipour retweeted
Excited to be attending #USCAP2025 with an incredible group of people! Grateful for the opportunity to learn, connect, and grow together. Looking forward to all the inspiring moments ahead! #Pathology
Maryam Mehdipour retweeted
Brilliant resident from GWU, future cytopathologist Maryam Mehdipour Dalivand @MaryamMpd, presenting poster where she integrates molecular pathology and cytopathology #USCAP25 #pathresidents,@GWSMHS,@GWPathology, #cytology, @cytopathology, #TheUSCAP
Maryam Mehdipour retweeted
As the director of a clinical microbiology laboratory in an academic medical center, Dr. Rebecca Yee loves that every day is a little different. “I know that no matter what I am doing that day, I am impacting the lives of someone—patients or trainees,” she says. Check out the latest 3 Questions with Dr. Yee to find out the impact she hopes to make and more. bit.ly/3BiED8N
Maryam Mehdipour retweeted
The ✅ diagnosis is T- large granular lymphocytic leukemia and the pathway is JAK-STAT (STAT5 and STAT3 mutations are most common)
Note how the LGL morphology is much more readily appreciated in PB (this image) compared to BM (image in original post). #hemepath
40ish y/o woman w/ rheumatoid arthritis, splenomegaly & neutropenia
Your diagnosis & most likely mutated pathway??
No poll… just free text b/c IRL, U don’t get multiple choice questions when U have e to make a Dx 😉
#hemepath
Maryam Mehdipour retweeted
Excited to present my poster at #CAP24! It’s an honor to share research with fellow pathologists and learn from so many inspiring presentations. @Pathologists @GWPathology @Abdo_Dabash @MaryamMpd
Maryam Mehdipour retweeted
Had the pleasure of meeting @DonKarcherMD at #CAP24. His expertise and insights into leadership are truly inspiring. A great opportunity to connect and learn from one of the best! @Pathologists @GWPathology @Abdo_Dabash @MaryamMpd
Maryam Mehdipour retweeted
#GUPath tweeps, what is unusual with this nephrogenic adenoma?
Answer in comment.
Maryam Mehdipour retweeted
“Architectural Diversity” is frequently touted as a hallmark feature of salivary gland “Polymorphous Adenocarcinoma” (PAC). Here is an example of a PAC on FNA of an intraoral mass simulating an adenoid cystic carcinoma. @DianaEstherossi
Maryam Mehdipour retweeted
Cytology case of the week! 30M with 1cm parotid nodule, present for 1year. (Mammaglobin (+), S100 (+), GATA3(+), mucicarmine (-)) Which genetic aberrations will confirm the diagnosis? #pathresidents,@GWSMHS,@GWPathology, #cytology,#cytopathology,#teachingcytopath,#PathTwitter
Maryam Mehdipour retweeted
Exciting times at Research Day @GWPathology ! Working with this amazing team has been truly inspiring! Here’s to pushing the boundaries of medical knowledge together. #PathTwitter #pathology

















































